A SAGE (serial analysis of gene expression) view of breast tumor progression.
about
S100A7 and the progression of breast cancerPI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.Large-scale cDNA transfection screening for genes related to cancer development and progressionLigand-independent activation of estrogen receptor alpha by XBP-1Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression dataA neural survival factor is a candidate oncogene in breast cancerGenetic alteration and gene expression modulation during cancer progressionThe diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesionsMethods to find out the expression of activated genesS100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breastTranscriptomic changes in human breast cancer progression as determined by serial analysis of gene expressionOverdispersed logistic regression for SAGE: modelling multiple groups and covariatesChanges in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.Mechanisms involved in breast cancer liver metastasisLarge scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinomaSerial analysis of gene expression study of a hybrid rice strain (LYP9) and its parental cultivars.Statistical analysis and significance testing of serial analysis of gene expression data using a Poisson mixture modelGene expression profiles of human breast cancer progression.From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasisS100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.Clustering-based approaches to SAGE data mining.Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cellsMyc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.Does HPV 16/18 infection affect p53 expression in invasive ductal carcinoma? An experimental studyCCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage.CCAAT/Enhancer Binding Protein-delta (C/EBP-delta) regulates cell growth, migration and differentiationThe tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cellsIdentification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinomaBreast cancer: origins and evolution.SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapseTumor vaccines for breast cancerSingle-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.
P2860
Q22000741-82CA1E53-9971-4665-8F9A-35171962E3F6Q22000770-58EEAEB8-7B5D-411D-B79D-96D25A25A40AQ24561958-179E5C1F-95E6-483E-9713-6B4C266DCC74Q24678871-6F590376-6895-456D-9FB1-0615F825CEA4Q24684071-CC0AF1F6-D40E-4980-8B33-CC0190CB1E37Q24685777-8555C6B5-B324-4D80-9CC4-5C23675C5BE8Q24798750-237C8A25-0597-4291-B64A-3A1BC397EB8DQ24803014-10E6026F-4B81-4CEC-BC5B-E3DC55ECB4C2Q24804002-CE2C7AB6-834B-4021-8855-480205FAE4A5Q24805971-0D9494DB-2BF9-4852-9014-658A684A2E37Q24806240-BE59B45B-0ADF-4257-89D7-4B786F62AE4FQ24806241-F6FC352C-373D-48FB-8C05-5752AE5271EEQ24812718-24D6B7C8-6144-4BDA-BA21-A8854FCE29FEQ28084024-26E06FB5-8282-4F23-B556-54E5295EF9DEQ30310086-F8565033-1B6C-4958-895F-942A1F3626D1Q30793247-552E5FC1-3501-4DF9-9BC0-23558A428622Q31121003-CCDA07C4-4FDE-4B3B-9FE3-8743B832A4C0Q33186821-0DA92716-D9C4-41BA-814B-EFF4B2F7B694Q33208592-03F929D7-A21F-4604-B4BB-68874D821A19Q33210156-0F8C472F-A3F4-4DE4-8F01-954B6E05D8C8Q33305131-CD2A69AD-8996-4341-A460-4FC1535233B3Q33368864-322F3A4F-9FA0-46EE-A570-80F05546D0CAQ33372457-7D4DA94B-86A6-43C7-B2CA-378CD52DD859Q33373166-14AA1743-CFD1-4A0C-8E2B-8D3634FECCD8Q33888111-08B9214D-5835-4808-9BA8-F2A7EA7EC180Q34001935-F0F511C7-0429-4734-930D-B969546A25C1Q34136207-C8C61D9E-E727-4A08-B14E-E6BBA092C057Q34419342-B86E3B64-9C86-4EA4-AEED-26F7D0B5D7C2Q34479984-F505AEAB-2BE4-4ED5-9735-763ECED6DB21Q34771278-292C64BD-C355-4A9C-9DFC-012B641E34DBQ35022551-DDB62426-0838-46DD-B35D-F5A1D6DBF7B3Q35075591-4D37ABB4-6AAE-4E24-8021-487BCB3EFD28Q35080755-276FBD29-CC5A-49C9-88DE-A4392C062EDBQ35665700-E5547E96-F08B-42C3-8D44-108BE393A30CQ36037099-82E910E6-01DB-46F1-A3F3-E1EC1AE8DBF3Q36099434-CF230715-A2AA-479B-9261-5C59CFB84FBCQ36132296-708B4CA3-E927-48D3-9C4B-2B9754EA76F1Q36166817-ED76541B-F078-450A-8511-2F60F85B0768Q36204803-9696B546-47FE-4B65-9140-FB0588998755Q36355592-A18CBBB4-FD7F-4C05-B4A9-544CD57675D6
P2860
A SAGE (serial analysis of gene expression) view of breast tumor progression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A SAGE (serial analysis of gene expression) view of breast tumor progression.
@ast
A SAGE (serial analysis of gene expression) view of breast tumor progression.
@en
type
label
A SAGE (serial analysis of gene expression) view of breast tumor progression.
@ast
A SAGE (serial analysis of gene expression) view of breast tumor progression.
@en
prefLabel
A SAGE (serial analysis of gene expression) view of breast tumor progression.
@ast
A SAGE (serial analysis of gene expression) view of breast tumor progression.
@en
P2093
P1433
P1476
A SAGE (serial analysis of gene expression) view of breast tumor progression
@en
P2093
P304
P407
P577
2001-08-01T00:00:00Z